Drug Profile
Zinc acetate - Teva Pharmaceuticals
Alternative Names: Galzin; Wilzin; Zinc acetate dihydrate - Teva PharmaceuticalsLatest Information Update: 30 Oct 2021
Price :
$50
*
At a glance
- Originator Lemmon
- Developer Orphan Europe; Teva Pharmaceuticals USA
- Class Acetates; Antiacnes; Antidiarrhoeals; Heavy metals
- Mechanism of Action Chelating agents
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Hepatolenticular degeneration
Most Recent Events
- 24 Jan 2019 Zinc acetate is not yet available for Hepatolenticular degeneration in Iceland and Liechtenstein (PO)
- 13 Aug 2015 Launched for Wilson's disease in Slovenia, Lithuania, Slovakia and Latvia (PO) before August 2015
- 30 Apr 2015 Launched for Wilson's disease in Greece (PO) before April 2015